| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | BRCA1 | Synonyms | BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q21.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | BRCA1 DNA repair associated | ||||
| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| GTO ID | GTC1380 |
| Trial ID | NCT01334047 |
| Disease | Epithelial Ovarian Cancer |
| Altered gene | BRCA1|TERT|BIRC5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | DC-006 Vaccine |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Phase I/II Trial of Vaccine Therapy in Recurrent Platinum Sensitive Epithelial Ovarian Cancer Patients Using Autologous Dendritic Cells Loaded With Amplified Ovarian Cancer Stem Cell mRNA, hTERT and Survivin. |
| Year | 2011 |
| Country | Norway |
| Company sponsor | Steinar Aamdal |
| Other ID(s) | DC-006 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||